Informações:
Falhas:
ID
33981
Descrição
A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01077713
Link
https://clinicaltrials.gov/show/NCT01077713
Palavras-chave
Versões (1)
- 09/01/2019 09/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
9 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT01077713
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT01077713
- StudyEvent: Eligibility
Similar models
Eligibility Non-Squamous Non-Small Cell Lung Cancer NCT01077713
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Adult | Age
Item
adult patients, >=70 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Metastatic Non-Squamous Non-Small Cell Lung Carcinoma Advanced Locally Inoperable
Item
inoperable, locally advanced, metastatic non-squamous non-small cell lung cancer;
boolean
C4288755 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C0205187 (UMLS CUI [1,4])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C0205187 (UMLS CUI [1,4])
Measurable lesion Quantity
Item
>=1 measurable lesion;
boolean
C1513041 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-1.
boolean
C1520224 (UMLS CUI [1])
Neoadjuvant Chemotherapy | Chemotherapy, Adjuvant
Item
neoadjuvant/adjuvant chemotherapy within 6 months prior to enrollment;
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C3665472 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
Therapeutic radiology procedure Radical Curative
Item
radical radiotherapy with curative intent within 28 days prior to enrollment;
boolean
C1522449 (UMLS CUI [1,1])
C0439807 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
C0439807 (UMLS CUI [1,2])
C1276305 (UMLS CUI [1,3])
Hemoptysis Grade
Item
history of >=grade 2 hemoptysis in 3 months prior to enrollment;
boolean
C0019079 (UMLS CUI [1,1])
C0441800 (UMLS CUI [1,2])
C0441800 (UMLS CUI [1,2])
CNS metastases
Item
evidence of cns metastases;
boolean
C0686377 (UMLS CUI [1])
Aspirin U/day | Anticoagulants Dose Full | Fibrinolytic Agents
Item
current or recent (within 10 days of first dose of avastin)use of aspirin (>325 mg/day)or full dose anticoagulants or thrombolytic agents for therapeutic purposes.
boolean
C0004057 (UMLS CUI [1,1])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])
C0456683 (UMLS CUI [1,2])
C0003280 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0443225 (UMLS CUI [2,3])
C0016018 (UMLS CUI [3])